|
Search concepts
|
|
Selected Filters
|
- 24,300 - 24,325 out of 25,312 results
Search results
-
Research project
The Role of EZH2 in High-Risk Non-Muscle Invasive Bladder Cancer
U.S. Army Medical Research and Materiel Command
8/1/16 → 8/1/16
Project: Research project
-
Chicago Biomedical Consortium - Main (2017-2021)
Searle Funds at The Chicago Community Trust
1/1/17 → 12/31/21
Project: Research project
-
Project 4 (NU) for Proteostasis in Aging and Neurodegenerative Disease
9/30/18 → 5/31/23
Project: Research project
-
Programmed re-modeling of the heat shock response underlies onset of ALS
8/1/13 → 7/31/15
Project: Research project
-
PDR-079: Reprogramming of the stress response in aging, implication for proteome maintenance and disease
Searle Funds at The Chicago Community Trust
1/1/11 → 6/30/17
Project: Research project
-
Regulation and Expression of the Human HSP70 Gene Family
National Institute of General Medical Sciences
4/1/02 → 3/31/03
Project: Research project
-
CBC - HTS Awards (Year 6-10)
Searle Funds at The Chicago Community Trust
1/1/11 → 12/31/17
Project: Research project
-
Support for research on the Proteostasis of Aging Biology
Glenn Foundation for Medical Research
9/28/15 → 9/27/17
Project: Research project
-
Core 2 (Harvard University) for Proteostasis in Aging and Neurodegenerative Disease
9/30/18 → 5/31/23
Project: Research project
-
Protocol No. MSDC-0602K-C009NASH: A Phase 2, Randomized, Double-Blind, Placebo-Controlled, 12-Month, Multiple-Dose Study to Evaluate the Safety, Tolerability and Efficacy of Three Dose Levels of MSDC 0602K in Patients with NASH (EMMINENCE™)
Rinella, M. E.
Chiltern International, Inc., Cirius Therapeutics, Inc.
12/18/17 → 12/18/20
Project: Research project
-
Minority Supplement for: Regulation and Expression of the HSP70 Gene Family
National Institute of General Medical Sciences
4/1/03 → 3/31/05
Project: Research project
-
Prot# GFT505-315-1: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of Elafibranor in Patients with Nonalcoholic Steatohepatitis (NASH) and fibrosis.
Rinella, M. E.
9/28/16 → 9/28/21
Project: Research project
-
Minority Supplement for Regulation and Gene Expression of the Human HSP70 Gene Family
National Institute of General Medical Sciences
6/1/03 → 8/15/03
Project: Research project
-
-
Prot #IS00006804: The Role of the PARPi Niraparib and Immunotherapy for Treatment of Urothelial Carcinoma
7/11/17 → 7/11/19
Project: Research project
-
Prot#18-0108: A Phase 2b, Randomized, Double-blind, Placebo-controlled, Multi-center Study to Evaluate the Efficacy, Safety, and Tolerability of Two Doses of NGM282 Administered for 24 Weeks for the Treatment of Histologically Confirmed Nonalcoholic Steat
Rinella, M. E.
Medpace Clinical Research LLC, NGM Biopharmaceuticals, Inc.
8/23/19 → 8/23/22
Project: Research project
-
Prot# MGL-3196-14: A 52-Week, Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients with Non-alcoholic Fatty Liver Disease (NAFLD) (MAESTRO-NAFLD-1)
Rinella, M. E.
Pharmaceutical Research Associates, Inc., Madrigal Pharmaceuticals, Inc.
7/28/20 → 7/28/23
Project: Research project
-
-
CBC - Catalysts Awards (Years 6-10)
Searle Funds at The Chicago Community Trust
1/1/11 → 12/31/17
Project: Research project
-
CBC - Recruitment Award (Years 6-10)
Searle Funds at The Chicago Community Trust
1/1/11 → 12/31/17
Project: Research project
-
Testing the Synergy of Veliparib and Immune Checkpoint Inhibitors in Treatment of Urothelial Carcinoma
9/29/17 → 9/29/19
Project: Research project
-
Ford Foundation Fellowship for Minorities
National Research Council, Ford Foundation
9/1/03 → 8/31/08
Project: Research project